Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 366

1.

The reliability and validity of ultrasound to quantify muscles in older adults: a systematic review.

Nijholt W, Scafoglieri A, Jager-Wittenaar H, Hobbelen JSM, van der Schans CP.

J Cachexia Sarcopenia Muscle. 2017 Jul 12. doi: 10.1002/jcsm.12210. [Epub ahead of print] Review.

2.

Are Antioxidants a Potential Therapy for FSHD? A Review of the Literature.

Denny AP, Heather AK.

Oxid Med Cell Longev. 2017;2017:7020295. doi: 10.1155/2017/7020295. Epub 2017 Jun 12. Review.

3.

Targeting Inflammation and Downstream Protein Metabolism in Sarcopenia: A Brief Up-Dated Description of Concurrent Exercise and Leucine-Based Multimodal Intervention.

Xia Z, Cholewa J, Zhao Y, Shang HY, Yang YQ, Araújo Pessôa K, Su QS, Lima-Soares F, Zanchi NE.

Front Physiol. 2017 Jun 22;8:434. doi: 10.3389/fphys.2017.00434. eCollection 2017. Review.

4.

The Role of the Heat Shock Protein B8 (HSPB8) in Motoneuron Diseases.

Rusmini P, Cristofani R, Galbiati M, Cicardi ME, Meroni M, Ferrari V, Vezzoli G, Tedesco B, Messi E, Piccolella M, Carra S, Crippa V, Poletti A.

Front Mol Neurosci. 2017 Jun 21;10:176. doi: 10.3389/fnmol.2017.00176. eCollection 2017. Review.

5.

Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature review.

Verhaart IEC, Robertson A, Wilson IJ, Aartsma-Rus A, Cameron S, Jones CC, Cook SF, Lochmüller H.

Orphanet J Rare Dis. 2017 Jul 4;12(1):124. doi: 10.1186/s13023-017-0671-8. Review.

6.

Spinal Muscular Atrophy: From Defective Chaperoning of snRNP Assembly to Neuromuscular Dysfunction.

Lanfranco M, Vassallo N, Cauchi RJ.

Front Mol Biosci. 2017 Jun 8;4:41. doi: 10.3389/fmolb.2017.00041. eCollection 2017. Review.

7.

Inherited Paediatric Motor Neuron Disorders: Beyond Spinal Muscular Atrophy.

Teoh HL, Carey K, Sampaio H, Mowat D, Roscioli T, Farrar M.

Neural Plast. 2017;2017:6509493. doi: 10.1155/2017/6509493. Epub 2017 May 28. Review.

9.

Splice-Switching Therapy for Spinal Muscular Atrophy.

Meijboom KE, Wood MJA, McClorey G.

Genes (Basel). 2017 Jun 12;8(6). pii: E161. doi: 10.3390/genes8060161. Review.

10.

The golden retriever model of Duchenne muscular dystrophy.

Kornegay JN.

Skelet Muscle. 2017 May 19;7(1):9. doi: 10.1186/s13395-017-0124-z. Review.

11.

MotomiRs: miRNAs in Motor Neuron Function and Disease.

Hawley ZCE, Campos-Melo D, Droppelmann CA, Strong MJ.

Front Mol Neurosci. 2017 May 4;10:127. doi: 10.3389/fnmol.2017.00127. eCollection 2017. Review.

12.

SUCLA2-Related Mitochondrial DNA Depletion Syndrome, Encephalomyopathic Form with Methylmalonic Aciduria.

El-Hattab AW, Scaglia F.

In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017.
2009 May 26 [updated 2017 May 18].

13.

Exercise and Protein Intake: A Synergistic Approach against Sarcopenia.

Martone AM, Marzetti E, Calvani R, Picca A, Tosato M, Santoro L, Di Giorgio A, Nesci A, Sisto A, Santoliquido A, Landi F.

Biomed Res Int. 2017;2017:2672435. doi: 10.1155/2017/2672435. Epub 2017 Mar 21. Review.

14.

Long-term non-invasive ventilation therapies in children: A scoping review.

Castro-Codesal ML, Dehaan K, Featherstone R, Bedi PK, Martinez Carrasco C, Katz SL, Chan EY, Bendiak GN, Almeida FR, Olmstead DL, Young R, Woolf V, Waters KA, Sullivan C, Hartling L, MacLean JE.

Sleep Med Rev. 2017 Mar 2. pii: S1087-0792(17)30046-1. doi: 10.1016/j.smrv.2017.02.005. [Epub ahead of print] Review.

15.

The Association between Imaging Parameters of the Paraspinal Muscles, Spinal Degeneration, and Low Back Pain.

Kalichman L, Carmeli E, Been E.

Biomed Res Int. 2017;2017:2562957. doi: 10.1155/2017/2562957. Epub 2017 Mar 20. Review.

16.

Cardiac pathology in spinal muscular atrophy: a systematic review.

Wijngaarde CA, Blank AC, Stam M, Wadman RI, van den Berg LH, van der Pol WL.

Orphanet J Rare Dis. 2017 Apr 11;12(1):67. doi: 10.1186/s13023-017-0613-5. Review.

17.

Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease.

Sardone V, Zhou H, Muntoni F, Ferlini A, Falzarano MS.

Molecules. 2017 Apr 5;22(4). pii: E563. doi: 10.3390/molecules22040563. Review.

18.

Non-alcoholic fatty liver disease connections with fat-free tissues: A focus on bone and skeletal muscle.

Poggiogalle E, Donini LM, Lenzi A, Chiesa C, Pacifico L.

World J Gastroenterol. 2017 Mar 14;23(10):1747-1757. doi: 10.3748/wjg.v23.i10.1747. Review.

19.

Maximum inspiratory pressure as a clinically meaningful trial endpoint for neuromuscular diseases: a comprehensive review of the literature.

Schoser B, Fong E, Geberhiwot T, Hughes D, Kissel JT, Madathil SC, Orlikowski D, Polkey MI, Roberts M, Tiddens HA, Young P.

Orphanet J Rare Dis. 2017 Mar 16;12(1):52. doi: 10.1186/s13023-017-0598-0. Review.

20.

On the Emerging Role of the Taste Receptor Type 1 (T1R) Family of Nutrient-Sensors in the Musculoskeletal System.

Kokabu S, Lowery JW, Toyono T, Sato T, Yoda T.

Molecules. 2017 Mar 15;22(3). pii: E469. doi: 10.3390/molecules22030469. Review.

Supplemental Content

Loading ...
Support Center